While solid evidence has demonstrated the protective roles of inflammasomes and IL-18 in AOM/DSS-induced colon cancer, it would be informative to determine whether inflammasomes, IL-1β or IL-18 inhibit or promote colon cancer development in chronic or genetic colon cancer models as well as in human colorectal cancer patients. This evidence concerns the gene IL18 and colonic neoplasm.